FDG-PET in aggressive non Hodgkin lymphoma: the prognostic value of interim evaluation

被引：0
|
作者：
Aloj, L. [1 ]
Frigeri, F. [2 ]
Caraco, C. [1 ]
Crisci, S. [2 ]
Farese, R. [3 ]
Ibello, F. [1 ]
Morisco, A. [3 ]
Capobianco, G. [2 ]
Volzone, F. [2 ]
Pinto, A. [2 ]
Lastoria, S. [1 ]
机构：
[1] Ist Nazl Tumori Fdn G Pascale IRCCS, SC Med Nucl, Naples, Italy
[2] Ist Nazl Tumori Fdn G Pascale IRCCS, SC Ematol, Naples, Italy
[3] Ist Nazl Tumori Fdn G Pascale IRCCS, Ctr Ric Oncol Mercogliano, Mercogliano, AV, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P733
引用
收藏
页码：S692 / S692
页数：1
相关论文
共 50 条
  • [21] Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review
    Adams, Hugo J. A.
    Nievelstein, Rutger A. J.
    Kwee, Thomas C.
    [J]. ANNALS OF HEMATOLOGY, 2016, 95 (01) : 11 - 18
  • [22] Prognostic value of the maximum standardized uptake value of staging FDG-PET/CT in Hodgkin lymphoma.
    Hu, Boyu
    Potluri, Alekhya
    Torigian, Drew A.
    Heltjan, Daniel F.
    Nasta, Sunita
    Schuster, Stephen J.
    Svoboda, Jakub
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] Prognostic Value of SUV in Interim 18F-FDG PET in Non-Hodgkin's Lymphoma Patients
    Cozar Santiago, M.
    Ferrer Rebolleda, J.
    Vicedo Gonzalez, A.
    Sanz Llorens, R.
    Aguilar Barrios, J.
    Devis Saiz, M.
    Sanchez Jurado, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S376 - S376
  • [24] Prognostic Value of Interim Chemotherapy 18F-FDG PET/CT in Pediatric Non-Hodgkin Lymphoma
    Wray, Rick
    Mena, Esther
    Solnes, Lilja
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [25] FDG-PET in Hodgkin's lymphoma
    Ruth Kirby
    [J]. Nature Clinical Practice Oncology, 2005, 2 (10): : 485 - 486
  • [26] Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma
    Al-Ibraheem, Akram
    Anwer, Farah
    Juweid, Malik E.
    Shagera, Qaid Ahmed
    Khalaf, Aysar N.
    Obeidat, Shahed
    Mansour, Areen
    Ma'koseh, Mohammad
    Halahleh, Khalid
    Jaradat, Imad
    Almasri, Nidal
    Mansour, Asem
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [27] Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
    Akram Al-Ibraheem
    Farah Anwer
    Malik E. Juweid
    Qaid Ahmed Shagera
    Aysar N. Khalaf
    Shahed Obeidat
    Areen Mansour
    Mohammad Ma’koseh
    Khalid Halahleh
    Imad Jaradat
    Nidal Almasri
    Asem Mansour
    [J]. Scientific Reports, 12
  • [28] Interim FDG-PET/CT in Hodgkin lymphoma: what are we actually looking at?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    [J]. ACTA ONCOLOGICA, 2018, 57 (08) : 1128 - 1130
  • [29] Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?
    Gallamini, Andrea
    Kostakoglu, Lale
    [J]. BLOOD, 2012, 120 (25) : 4913 - 4920
  • [30] Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long term follow-up results
    Molnar, Z. S.
    Borbenyi, Z.
    Galuska, L.
    Keresztes, K.
    Marton, I.
    Rosta, A.
    Simon, Z. S.
    Tron, L.
    Illes, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 73 - 73
12345